Paul Henderson

I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations

L. Esserman, J. Beitler, S. Gandotra, 2022, BMJ Open.

Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial

L. Esserman, R. Wahab, R. Wunderink, 2023, eClinicalMedicine.

I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations

L. Esserman, J. Beitler, S. Gandotra, 2022, BMJ Open.